UK markets closed

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.81-0.25 (-3.54%)
As of 12:58PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3354
Avg. Estimate-0.52-0.55-1.92-0.11
Low estimate-0.65-0.69-2.66-0.82
High estimate-0.42-0.46-1.330.97
Year ago EPS-0.43-0.58-1.83-1.92
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3355
Avg. EstimateN/AN/AN/A71.53M
Low estimateN/AN/AN/A28.97M
High estimateN/AN/AN/A141.3M
Year ago salesN/AN/A81kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.42-0.48-0.53-0.54
Actual EPS-0.43-0.58-0.49-0.34
Difference-0.01-0.10.040.2
Surprise %-2.40%-20.80%7.50%37.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.52-0.55-1.92-0.11
7 days ago-0.45-0.47-1.730.04
30 days ago-0.61-0.63-1.87-0.2
60 days ago-0.61-0.63-1.89-0.23
90 days ago-0.61-0.63-1.9-0.2
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A1N/AN/A
Up last 30 days1223
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesATNMIndustrySector(s)S&P 500
Current qtr.-20.90%N/AN/AN/A
Next qtr.5.20%N/AN/AN/A
Current year-4.90%N/AN/AN/A
Next year94.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A